Full-Time

Pharmacy Tech Specialist

Oncology

Brown University Health

Brown University Health

1-10 employees

Remote behavioral health care platform analytics

Compensation Overview

$24.68 - $25.22/hr

Providence, RI, USA

In Person

Category
Medical, Clinical & Veterinary (1)
Required Skills
Inventory Management
Requirements
  • High school graduate or equivalent degree required. Completion of one to two years of college preferred.
  • Maintains current unrestricted Rhode Island Pharmacy Technician II licensure.
  • Maintains current National Pharmacy Technician Certification (CPhT).
  • Minimum 3 years' experience as a pharmacy technician, including 2 years investigational, oncology and/or sterile compounding experience preferably gained in a similarly diverse and operationally complex health care environment.
  • Knowledge of pharmacy information systems, automated dispensing technology, and personal computers.
  • Demonstrates excellent written and verbal interpersonal and communication skills.
  • Must have the ability to multi-task and reprioritize as needed while maintaining accuracy and service standards.
  • Must obtain, within 2 months of hire, and maintain no less than semi-annually thereafter, internal IV and oncology credentialing as demonstrated by successful completion of current competency assessments.
Responsibilities
  • Is responsible for knowing and acting in accordance with the principles of the Brown University Health Corporate Compliance Program and Code of Conduct.
  • Under the supervision of an Oncology Pharmacist, the Oncology Technician Specialist:
  • Ensures the sterile compounding environment and all equipment are cleaned and maintained under aseptic conditions and in accordance with departmental standard operating procedures.
  • Performs hand hygiene and garbing practices in accordance with departmental standard operating procedures.
  • Performs sterile compounding of medications in compliance with USP 797, USP 800, National Institute for Occupational Safety and Health (NIOSH) recommendations and Brown University Health policies and procedures.
  • Performs non-sterile compounding in compliance with USP 795, USP 800, National Institute for Occupational Safety and Health (NIOSH) recommendations and Brown University Health policies and procedures.
  • Completes accurate documentation of compounded medications per Brown University Health policies and procedures.
  • Performs sterile and non-sterile compounding of investigational medications in compliance with specific investigational medication protocol.
  • Performs computer activities necessary for compounding. Understands and appropriately follows requirements for product documentation and check processes. Completes accurate documentation of finished compounded medications per policy.
  • Sets up, calibrates, and operates ancillary compounding equipment (i.e., pumps) appropriately.
  • Delivers compounded medication ensuring proper storage location requirements are met based on stability needs of the product.
  • Collaborates with pharmacy oncology and purchasing teams to procure oncology and infusion medications, and related supplies in a timely manner.
  • Collaborates with pharmacy oncology team ensure oncology and other hazardous medications are segregated.
  • Manages inventory including receiving, sorting, stocking, rotation of stock, expiration date checking, and disposal per policy.
  • Tracks temperature monitoring and other environmental controls as applicable to oncology and infusion medication storage. Understands how to triage out of range controls.
  • Transfers oncology and infusion medications to off-site satellite locations, as necessary.
  • Performs recordkeeping and filing tasks, collates work volume statistics.
  • Shares expertise by participating in the orientation and training of pharmacy technicians, student interns, and student externs.
  • Exhibits proactive problem solving to help address issues impacting pharmacy oncology services.
  • Performs all duties of other Pharmacy Technician job categories as may be required.
Brown University Health

Brown University Health

View

Memoir Health provides a behavioral healthcare platform that enables home-based care for behavioral health and substance use issues. It helps health systems remotely manage patients with tools like remote patient monitoring, scheduling, virtual care, and outcomes management, powered by a data analytics engine that highlights cost-saving opportunities and supports automated workflows and one-click referrals. The platform differentiates itself by automating care journeys and delivering integrated, outcomes-focused care within managed care and other healthcare networks, reducing administrative workload for clinicians. Its goal is to make care more proactive, accessible, and coordinated from patients’ homes, improving outcomes while lowering costs, and Memoir Health was later acquired by Lumeo Health in 2020.

Company Size

1-10

Company Stage

Seed

Total Funding

$7.5M

Headquarters

New York City, New York

Founded

2018

Simplify Jobs

Simplify's Take

What believers are saying

  • Multi-million dollar annual investments expand academic-clinical integration.
  • Rhode Island Hospital and Bradley specialize in behavioral health training.
  • Outpatient networks align with home-based behavioral care coordination.

What critics are saying

  • TriZetto cyber incident disrupts Brown University Health billing March 2026.
  • Lyra Health erodes employer behavioral health market share in New England.
  • Medicaid redetermination disenrolls 20-30% behavioral patients ongoing.

What makes Brown University Health unique

  • STAT program offers free certification for entry-level healthcare roles.
  • Exclusive teaching affiliate of Warren Alpert Medical School at Rhode Island Hospital.
  • Community Health Institute delivers Rhode Island-focused proactive care initiatives.

Help us improve and share your feedback! Did you find this helpful?

Your Connections

People at Brown University Health who can refer or advise you

Benefits

Health Insurance

Dental Insurance

Vision Insurance

401(k) Retirement Plan

Flexible Work Hours

Remote Work Options

Paid Vacation

Paid Holidays

Paid Sick Leave

Productivity Bonus

Stock Options

Company Equity

Conference Attendance Budget

Wellness Program

Mental Health Support

Gym Membership

Phone/Internet Stipend

Home Office Stipend

Family Planning Benefits

Fertility Treatment Support

Adoption Assistance

Parental Leave

Loan Assistance

Professional Development Budget

Education allowance

Tuition Reimbursement

Professional Certification Support

Mentorship Program

Commuter Benefits

Meal Benefits

Medical Insurance

Life Insurance

Disability Insurance

Company News

PBN
Apr 25th, 2023
Miriam Hospital’s palliative care program is first in R.I. and one of few in U.S.

LIFESPAN CORP. and HopeHealth launched the state’s first palliative care program in the emergency department of The Miriam Hospital.

PBN
Jan 4th, 2023
Markell named New CFO of Lifespan Corp.

PETER K. MARKELL was named Lifespan Corp. ’s new chief financial officer and executive vice president, starting Jan. 30.

PBN
Dec 26th, 2022
Pareek appointed chief of urology for Lifespan hospitals

PROVIDENCE – Lifespan Corp. has appointed Dr. Gyan Pareek as chief of urology in the department of surgery at Lifespan hospitals and president of Brown Urology Inc.

PBN
Dec 15th, 2022
Lifespan Cancer Institute launches career program for young people of color

PROVIDENCE – The Lifespan Cancer Institute is launching a new program to train high school students of color for a career in cancer research and medicine.

Business Wire
Dec 15th, 2022
Trisalus Life Sciences Highlights Pressure-Enabled Regional Immuno-Oncology™ (Perio™) Clinical Trial Progress And Pre-Clinical Research Developments

DENVER & CHICAGO--(BUSINESS WIRE)--TriSalus Life Sciences®, Inc. (“TriSalus” or the “company”), an oncology company in the process of going public through a business combination transaction (the “Business Combination”) with MedTech Acquisition Corporation (Nasdaq: MTAC) (“MedTech” or “MTAC”), today announced that it has expanded the reach of its ongoing Pressure-Enabled Regional Immuno-Oncology™ (“PERIO™-01” and “PERIO™-02”) clinical program.In recent months TriSalus has opened five new PERIO™-01 (NCT04935229) clinical trial sites, at Stanford University Hospitals, University of California Los Angeles, University of Colorado’s Anschutz Medical Campus, University of Washington Medical Center and University of Miami’s Sylvester Comprehensive Cancer Center, in addition to five previously activated sites. The PERIO™-01 trial is studying an investigational drug, SD-101, delivered intravascularly by the TriNav® Infusion System (“TriNav®”) using the company’s proprietary Pressure-Enabled Drug Delivery™ (“PEDD™”) method of administration. The study is evaluating whether this platform approach with SD-101 and PEDD™ can improve the performance of systemic checkpoint inhibitors in treating patients with uveal melanoma with liver metastases. In addition to these U.S. sites, TriSalus anticipates opening future PERIO™-01 clinical trial sites in the United Kingdom, Europe, and Canada.In parallel, TriSalus opened PERIO™-02 (NCT05220722) trial sites at Columbia University and University of Colorado Denver, along with Rhode Island Hospital – which was announced last month as part of an expanded research collaboration with Lifespan Health System